BioFabUSA will exhibit and present at DMC 2026, sharing how scalable biomanufacturing can strengthen U.S. defense capabilities and support resilient manufacturing systems.
A webinar series from the Cato T. Laurencin Institute for Regenerative Engineering highlighting cutting-edge research and the mentorship dynamics shaping the next generation of scientists.
ARMI will attend RAPID + TCT 2026 to explore the intersection of additive manufacturing and biomanufacturing, driving innovation in regenerative healthcare solutions.
A webinar series from the Cato T. Laurencin Institute for Regenerative Engineering highlighting cutting-edge research and the mentorship dynamics shaping the next generation of scientists.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
